Maravai LifeSciences Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Maravai LifeSciences Holdings, Inc. (MRVI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $5.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-02-26
- Maravai LifeSciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $5.00M, a 52.83% decline from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $10.60M, a 10.92% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $11.90M, a 54.55% increase from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $7.70M, a 79.07% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|
| 2025-12-31 | $5.00M 10-K · filed 2026-02-26 |
| 2024-12-31 | $10.60M 10-K · filed 2026-02-26 |
| 2023-12-31 | $11.90M 10-K · filed 2026-02-26 |
| 2022-12-31 | $7.70M 10-K · filed 2025-03-18 |
| 2021-12-31 | $4.30M 10-K · filed 2024-02-29 |